Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Mometasone furoate: Metaspray nasal spray by cipla
one spray (50mcg) in each nostril
once daily for 4 weeks
Control Intervention1: Fluticasone furoate: Furamist nasal spray by cipla
one
Sponsors
Dr Shubham jain
Eligibility
Inclusion criteria
Inclusion criteria: Children between 6 and 18 years of either gender with history of having or diagnosed allergic rhinitis.Allergic rhinitis is characterized by nasal blockage, rhinorrhea, sneezing and itching; any 2 of the above 4 symptoms must be present for >1hr every day for >2weeks to diagnose allergic rhinitis. Children with allergic rhinitis whose parents could understand and were able to adhere to the dosing and visit schedules and agreed to record the events accurately and consistently.
Exclusion criteria
Exclusion criteria: Children with any known Comorbid condition. Children with symptoms of rhinitis with fever. Children whose parents do not give consent. Children who are already being treated with intranasal corticosteroids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare efficacy of mometasone furoate with fluticasone furoate nasal sprays in children with allergic rhinitisTimepoint: 1st week and 4th week | — |
Secondary
| Measure | Time frame |
|---|---|
| relief in symptoms of allergic rhinitisTimepoint: 1st week and 4th week | — |
Countries
India
Contacts
Public ContactDr Shubham jain
Geetanjali medical college and hospital
Outcome results
None listed